SNPs
Stage
Allele /Genotype GD patients (%) Healthy controls (%)
P value
Pc value
OR (95% CI)
rs3118470 First C 262(43.667) 611(51.002) 0.004 NS 0.745(0.611-0.907)
(IL2RA) T 338(56.333) 587(48.998) 0.004 NS 1.343(1.103-1.635)
CC 72(24.000) 165(27.546) 0.262 NS 0.831(0.603-1.14)
CT 118(39.333) 281(46.912) 0.033 NS 0.734(0.554-0.973)
TT 110(36.667) 153(25.543) 0.001 0.027* 1.688(1.253-2.274)
Second C 299(44.627) 682(49.636) 0.033 NS 0.818(0.679-0.984)
T 371(55.373) 692(50.364) 0.033 NS 1.223(1.016-1.472)
CC 69(20.597) 177(25.764) 0.070 NS 0.747(0.545-1.024)
CT 161(48.060) 328(47.744) 0.924 NS 1.013(0.780-1.315)
TT 105(31.343) 182(26.492) 0.105 NS 1.267(0.951-1.687)
Combined C 561(44.173) 1293(50.272) 3.725×10-4 1.490×10-3 0.783(0.684-0.896)
T 709(55.827) 1279(49.728) 3.725×10-4 1.490×10-3 1.278(1.116-1.462)
CC 141(22.205) 342(26.594) 0.037 NS 0.788(0.630-0.986)
CT 279(43.937) 609(47.356) 0.157 NS 0.871(0.720-1.055)
TT 215(33.858) 335(26.050) 3.687×10-4 2.212×10-3 1.453(1.182-1.786)
rs2104286 First A 505(84.167) 952(79.333) 0.015 NS 1.385(1.068-1.796)
(IL2RA) G 95(15.833) 248(20.667) 0.015 NS 0.722(0.557-0.936)
AA 224(74.667) 384(64.000) 0.001 0.027* 1.658(1.217-2.258)
AG 57(19.000) 184(30.667) 1.710×10-4 4.617×10-3* 0.530(0.379-0.745)
GG 19(6.333) 32(5.333) 0.543 NS 1.200(0.668-2.155)
Second A 569(81.988) 1094(78.143) 0.040 NS 1.273(1.010-1.605)
G 125(18.012) 306(21.857) 0.040 NS 0.785(0.623-0.990)
AA 250(72.046) 430(61.429) 0.001 0.006 1.618(1.224-2.140)
AG 69(19.885) 234(33.429) 5.389×10-6 3.233×10-5 0.494(0.364-0.672)
GG 28(8.069) 36(5.143) 0.063 NS 1.619(0.971-2.700)
Combined A 1074(82.998) 2046(78.692) 0.002 0.008 1.322(1.112-1.571)
G 220(17.002) 554(21.308) 0.002 0.008 0.757(0.636-0.899)
AA 474(73.261) 814(62.615) 2.924×10-6 1.754×10-5 1.636(1.330-2.012)
AG 126(19.474) 418(32.154) 4.274×10-9 2.564×10-8 0.510(0.407-0.640)
GG 47(7.264) 68(5.230) 0.073 NS 1.419(0.966-2.084)